# Jiangsu Kangbeide Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-kangbeide-pharmaceutical-co

- Industry: Pharmaceuticals
- Headquarters: Nanjing, China
- Website: www.kbdpharm.com
- Latest round: Series A (Jun 29, 2015)
- Investors on record: 4

## About

Established in 2008 and based in Nanjing, China, Jiangsu Kangbeide Pharmaceutical Co., Ltd. operates as pharmaceutical company dedicated to providing transdermal patches and topical gel patches. It acquired 7 patents and 19 registered trademarks. In June 2015, Jiangsu Kangbeide Pharmaceutical Co., Ltd. closed series A funding from new investors Hairong Capital, Ruomu Capital, Think Investment Management, Zhejiang Aoyin Asset Management and individual investors. In August 2016, Jiangsu Kangbeide Pharmaceutical Co., Ltd. listed on the New Third Board (NEEQ).

The company mainly provides transdermal patches and gel ointments The transdermal patches include 11 products, different transdermal patches are suitable for different conditions such as overactive bladder, Parkinson's disease, depression, and asthma. The gel ointments include antipyretic patch, biphenylacetic acid gel ointment, and lidocaine gel ointment. The biphenylacetic acid gel ointment is suitable for degenerative joint disease, tendon and facial low back pain, and shoulder polyarthritis. The lidocaine gel ointment is suitable for postherpetic neuralgia.

## Funding rounds

- Series A, Jun 29, 2015 — Beijing Haina Yourong Capital, Think Investment Management, Ruomu Capital, Zhejiang Aoyin Asset Management

## Investors

- Beijing Haina Yourong Capital (https://capitalatlas.ai/funds/beijing-haina-yourong-capital) — Series A
- Think Investment Management — Series A
- Ruomu Capital — Series A
- Zhejiang Aoyin Asset Management — Series A